Add like
Add dislike
Add to saved papers

Evaluation of the expected ventilatory response to metabolic acidosis in chronic hemodialysis patients.

INTRODUCTION: Expected pCO2 during metabolic acidosis should be computed to rule out superimposing respiratory acid-base disorders, the latter being featured by too high or too low pCO2 than expected. At least 4 different and inconsistent formulas exist. Based on the common practical rule, the reduction of pCO2 equals 1.2 multiplied by the reduction of serum bicarbonate ([HCO3-]), whereas pCO2 equals to the 2 digit after pH decimal point according to Fulop. Instead, based on Winters' formula, pCO2 equals to 1.5 times [HCO3-] + 8. Finally, a very simple formula has been proposed, it reads pCO2  = [HCO3-] + 15. Beyond the evident simplicity, the latter has been effective in a small hemodialysis cohort but validation in a larger dataset is highly desirable.

METHODS: Formulas have been applied to 180 hemodialysis patients' blood samples dataset featured by mild metabolic acidosis (HCO3  ≥ 14 mEq/L) and root mean square errors (RMSE) associated with each formula were computed. pCO2 reference range was computed as expected pCO2  ± 2 RMSE.

FINDINGS: Fulop's rule and Winters' formula are associated with large prediction errors. Conversely, the common practical rule and the very simple formula are both featured by the same low error (1.7 mmHg). They further show good agreement and pick out the same reference range.

DISCUSSION: Superimposing respiratory acid-base disorders can be promptly and effectively ruled out by computing expected pCO2 as [HCO3-] + 15, a very simple formula proved to be interchangeable with the common practical rule that requires computes and assumptions, but leads to same results.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app